<?xml version="1.0" encoding="UTF-8"?>
<ref id="B225-pharmaceuticals-14-00381">
 <label>225.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Schwarz</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Sauter</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Karioti</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Bilia</surname>
    <given-names>A.R.</given-names>
   </name>
   <name>
    <surname>Efferth</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Schwarz</surname>
    <given-names>W.</given-names>
   </name>
  </person-group>
  <article-title>Kaempferol derivatives as antiviral drugs against the 3a channel protein of coronavirus</article-title>
  <source>Planta Med.</source>
  <year>2014</year>
  <volume>80</volume>
  <fpage>177</fpage>
  <lpage>182</lpage>
  <pub-id pub-id-type="doi">10.1055/s-0033-1360277</pub-id>
  <?supplied-pmid 24458263?>
  <pub-id pub-id-type="pmid">24458263</pub-id>
 </element-citation>
</ref>
